|4Feb 26, 5:03 PM ET

BIRD ROGER 4

4 · ABBOTT LABORATORIES · Filed Feb 26, 2019

Insider Transaction Report

Form 4
Period: 2019-02-22
BIRD ROGER
Senior Vice President
Transactions
  • Award

    Common shares without par value

    2019-02-22+19,02177,195 total
  • Award

    Option (right to buy)

    2019-02-22+99,70699,706 total
    Exercise: $75.90From: 2020-02-22Exp: 2029-02-21Common shares (99,706 underlying)
Footnotes (2)
  • [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
  • [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 33,235 on February 22, 2020, 33,235 on February 22, 2021, and 33,236 on February 22, 2022.

Documents

2 files